Variant report
Variant | rs7196161 |
---|---|
Chromosome Location | chr16:31110981-31110982 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:31100200..31102542-chr16:31110001..31111545,2 | MCF-7 | breast: | |
2 | chr16:30968246..30969827-chr16:31109716..31111519,2 | K562 | blood: | |
3 | chr16:31096486..31099181-chr16:31109176..31111486,2 | MCF-7 | breast: | |
4 | chr16:31109918..31113931-chr16:31122507..31126831,4 | MCF-7 | breast: | |
5 | chr16:31109802..31112036-chr16:31115940..31118854,2 | K562 | blood: | |
6 | chr16:31106219..31108190-chr16:31108513..31111355,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000255439 | TF binding region |
VKORC1 | TF binding region |
ENSG00000099381 | Chromatin interaction |
ENSG00000151006 | Chromatin interaction |
ENSG00000103507 | Chromatin interaction |
ENSG00000255439 | Chromatin interaction |
ENSG00000167397 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1060506 | 0.95[ASN][1000 genomes] |
rs10871454 | 0.85[ASN][1000 genomes] |
rs1108431 | 0.89[ASN][1000 genomes] |
rs11150604 | 0.89[ASN][1000 genomes] |
rs11640767 | 0.86[ASN][1000 genomes] |
rs11640957 | 0.86[ASN][1000 genomes] |
rs11642003 | 0.82[ASN][1000 genomes] |
rs11642192 | 0.98[ASN][1000 genomes] |
rs11647284 | 1.00[ASN][1000 genomes] |
rs11647442 | 0.87[AFR][1000 genomes];0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs11862744 | 0.89[ASN][1000 genomes] |
rs11864806 | 1.00[ASN][1000 genomes] |
rs11864839 | 1.00[ASN][1000 genomes] |
rs11865038 | 1.00[ASN][1000 genomes] |
rs11865499 | 0.95[ASN][1000 genomes] |
rs12445650 | 0.89[ASN][1000 genomes] |
rs12448321 | 0.89[ASN][1000 genomes] |
rs12597511 | 0.88[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs12716981 | 0.90[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs12716982 | 0.81[AMR][1000 genomes];0.93[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs12934418 | 0.89[ASN][1000 genomes] |
rs14235 | 0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs1549293 | 0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs17839567 | 0.89[ASN][1000 genomes] |
rs17839568 | 1.00[ASN][1000 genomes] |
rs1978485 | 0.89[AFR][1000 genomes];0.84[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs1978487 | 0.89[AFR][1000 genomes];0.84[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs2032915 | 0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs2288004 | 0.81[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2303222 | 0.84[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2303223 | 0.98[ASN][1000 genomes] |
rs2359612 | 0.83[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2855475 | 0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs28725459 | 0.91[ASN][1000 genomes] |
rs28814987 | 1.00[ASN][1000 genomes] |
rs2884738 | 0.95[ASN][1000 genomes] |
rs34649473 | 0.85[ASN][1000 genomes] |
rs35351013 | 0.93[ASN][1000 genomes] |
rs35468353 | 0.89[ASN][1000 genomes] |
rs35713203 | 1.00[ASN][1000 genomes] |
rs3751855 | 1.00[ASN][1000 genomes] |
rs4468641 | 1.00[ASN][1000 genomes] |
rs4527034 | 0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs4889530 | 0.81[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4889619 | 0.82[AMR][1000 genomes];0.89[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs4889620 | 0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs55766044 | 0.95[ASN][1000 genomes] |
rs55979739 | 0.89[ASN][1000 genomes] |
rs56284083 | 0.89[ASN][1000 genomes] |
rs56314408 | 0.89[AFR][1000 genomes];0.91[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs56813533 | 0.93[ASN][1000 genomes] |
rs57434408 | 0.91[ASN][1000 genomes] |
rs58726213 | 0.87[ASN][1000 genomes] |
rs59061704 | 0.86[ASN][1000 genomes] |
rs59735493 | 0.95[ASN][1000 genomes] |
rs60996860 | 0.91[ASN][1000 genomes] |
rs61162043 | 0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs61320757 | 0.95[ASN][1000 genomes] |
rs6565217 | 1.00[ASN][1000 genomes] |
rs7187995 | 0.93[ASN][1000 genomes] |
rs7196726 | 1.00[ASN][1000 genomes] |
rs7197717 | 1.00[ASN][1000 genomes] |
rs7199949 | 1.00[ASN][1000 genomes] |
rs7294 | 1.00[ASN][1000 genomes] |
rs732172 | 0.89[ASN][1000 genomes] |
rs732173 | 0.89[ASN][1000 genomes] |
rs73530203 | 0.98[ASN][1000 genomes] |
rs749670 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs749671 | 1.00[ASN][1000 genomes] |
rs749767 | 0.86[AMR][1000 genomes];0.93[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs7500176 | 0.89[ASN][1000 genomes] |
rs750952 | 1.00[ASN][1000 genomes] |
rs8047803 | 1.00[ASN][1000 genomes] |
rs8050894 | 0.88[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs8056842 | 0.89[ASN][1000 genomes] |
rs8061047 | 0.93[ASN][1000 genomes] |
rs881929 | 1.00[ASN][1000 genomes] |
rs889548 | 0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs889555 | 0.95[ASN][1000 genomes] |
rs9923231 | 0.83[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs9925964 | 0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs9929899 | 0.81[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs9934438 | 0.83[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs9936329 | 0.89[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs9939417 | 0.89[ASN][1000 genomes] |
rs9939558 | 0.89[ASN][1000 genomes] |
rs9972727 | 0.87[EUR][1000 genomes];0.95[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1062456 | chr16:30442166-31253997 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 437 gene(s) | inside rSNPs | diseases |
2 | nsv542898 | chr16:30442166-31253997 | Enhancers Active TSS Strong transcription Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 437 gene(s) | inside rSNPs | diseases |
3 | nsv905729 | chr16:30642867-31247924 | Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 387 gene(s) | inside rSNPs | diseases |
4 | nsv431451 | chr16:30682399-31340999 | Transcr. at gene 5' and 3' Genic enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 350 gene(s) | inside rSNPs | diseases |
5 | nsv905734 | chr16:30877544-31191482 | Active TSS Strong transcription Weak transcription Enhancers ZNF genes & repeats Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 271 gene(s) | inside rSNPs | diseases |
6 | nsv905735 | chr16:30890538-31247924 | Strong transcription Genic enhancers Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 264 gene(s) | inside rSNPs | diseases |
7 | nsv457483 | chr16:30903679-31191482 | Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers Strong transcription Enhancers ZNF genes & repeats Weak transcription Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 253 gene(s) | inside rSNPs | diseases |
8 | nsv571820 | chr16:30903679-31191482 | Enhancers Genic enhancers Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 253 gene(s) | inside rSNPs | diseases |
9 | esv1797877 | chr16:30948643-31188432 | Flanking Active TSS Enhancers Weak transcription Strong transcription Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 114 gene(s) | inside rSNPs | diseases |
10 | nsv833193 | chr16:30960796-31133604 | Enhancers Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 109 gene(s) | inside rSNPs | diseases |
11 | nsv905740 | chr16:31066249-31232437 | Flanking Active TSS Enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Active TSS Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 202 gene(s) | inside rSNPs | diseases |
12 | nsv905741 | chr16:31066249-31247924 | Genic enhancers Weak transcription Flanking Active TSS Active TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 202 gene(s) | inside rSNPs | diseases |
13 | nsv905742 | chr16:31102321-31247924 | Weak transcription Active TSS Strong transcription Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 188 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:31106800-31117200 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
2 | chr16:31107200-31111400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr16:31107400-31111200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
4 | chr16:31107400-31111200 | Weak transcription | K562 | blood |
5 | chr16:31107400-31111400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr16:31107400-31117200 | Weak transcription | NHLF | lung |
7 | chr16:31107600-31111600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
8 | chr16:31110000-31111800 | Weak transcription | Osteobl | bone |
9 | chr16:31110600-31111400 | Weak transcription | Esophagus | oesophagus |